OMEPRAZOLE Side Effects

7023688-8 | Cutaneous Lupus Erythematosus
on Sep 16, 2010 Female patient from UNITED KINGDOM , 78 years of age, was diagnosed with temporal arteritis and was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: cutaneous lupus erythematosus. Omeprazole dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

7023687-6 | Cutaneous Lupus Erythematosus
Patient was taking Omeprazole (View Usage). Patient had the following side effects: cutaneous lupus erythematosus on Sep 16, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 85 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?) and. Omeprazole dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

7023573-1 | Haematemesis, Hepatitis Acute, Weight Increased
Adverse event was reported on Sep 17, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: ) was diagnosed with dyspepsia, asthma (What is asthma?), abdominal pain (What is abdominal pain?), insomnia and. Location: UNITED KINGDOM , 28 years of age, weighting 104.7 lb, After Omeprazole was administered, patient had the following side effects: haematemesis, hepatitis acute, weight increased. During the same period patient was treated with BUDESONIDE (View Budesonide Review and Budesonide Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ). Patient was hospitalized.

7022255-X | Gastritis Erosive, Hepatic Enzyme Increased
on Sep 16, 2010 Male patient from RUSSIAN FEDERATION , weighting 211.6 lb, was diagnosed with acute coronary syndrome and was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: gastritis erosive, hepatic enzyme increased. Omeprazole dosage: . During the same period patient was treated with RIVAROXABAN (View Rivaroxaban Review and Rivaroxaban Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.


7022247-0 | Blood Creatine Increased, Renal Failure, Tubulointerstitial Nephritis
on Sep 23, 2010 Female patient from UNITED STATES , 44 years of age, weighting 190.0 lb, was diagnosed with dyspepsia, gastrooesophageal reflux disease, blood cholesterol increased and was treated with Omeprazole (View Usage). Patient had the following side effects: blood creatine increased, renal failure, tubulointerstitial nephritis. Omeprazole dosage: . During the same period patient was treated with PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), MAXZIDE (37.5/25mg - 1/2 Tablet) (View Maxzide Review and Maxzide Label ).

7021683-6 | Cutaneous Lupus Erythematosus
Patient was taking Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: cutaneous lupus erythematosus on Sep 16, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 76 years of age, was diagnosed with temporal arteritis and. Omeprazole dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

7021604-6 | Haematemesis, Hepatitis Acute, Weight Increased
Adverse event was reported on Sep 17, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: 20 Mg; Po) was diagnosed with abdominal pain upper, vomiting and. Location: UNITED KINGDOM , 28 years of age, Patient experienced the following unwanted or unexpected effects: haematemesis, hepatitis acute, weight increased. During the same period patient was treated with BUDESONIDE (View Budesonide Review and Budesonide Label ), DOMPERIDONE (DOMPERIDONE) (View Domperidone (domperidone) Review and Domperidone (domperidone) Label ), SALBUTAMOL (SALBUTAMOL) (View Salbutamol (salbutamol) Review and Salbutamol (salbutamol) Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ). Patient was hospitalized.

7020539-2 | Device Related Infection, Gastritis, Off Label Use, Pain
on Sep 20, 2010 Female patient from BRAZIL , 64 years of age, weighting 116.8 lb, was diagnosed with gastritis, breast cancer (What is breast cancer?), device failure, bone density decreased, arrhythmia (What is arrhythmia?) and was treated with Omeprazole (View Usage). Patient had the following side effects: device related infection, gastritis, off label use, pain (What is pain?). Omeprazole dosage: . During the same period patient was treated with ANASTROZOLE (View Anastrozole Review and Anastrozole Label ), NEXIUM (View Nexium Review and Nexium Label ), ACCOLATE (View Accolate Review and Accolate Label ), SODIUM ALENDRONATE (View Sodium Alendronate Review and Sodium Alendronate Label ), PROPAFENONE HCL (View Propafenone Hcl Review and Propafenone Hcl Label ). Patient was hospitalized.

7020406-4 | Hypocalcaemia, Tetany
on Sep 12, 2010 Female patient from UNITED KINGDOM , 46 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: hypocalcaemia, tetany. Omeprazole dosage: Dose: 20 Mg Milligram(s) Oral. During the same period patient was treated with AQUEOUS CREAM (View Aqueous Cream Review and Aqueous Cream Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ).

7020405-2 | Blood Sodium Decreased, Confusional State, Overdose
Patient was taking Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: blood sodium decreased, confusional state, overdose on Sep 12, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 77 years of age, was diagnosed with dyspepsia, hypertension and. Omeprazole dosage: Oral. During the same period patient was treated with BENDROFLUMETHIAZIDE (Dose: 2.5 Mg Milligram(s) Sep. Dosages / Interval: 1 In 1 Day Oral) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

7019549-0 | Dysphagia, Hypoaesthesia Oral, Lip Swelling, Swollen Tongue
Adverse event was reported on Sep 08, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: 20 Mg Ocne A Day, Oral) was diagnosed with gastrooesophageal reflux disease and. Location: UNITED STATES , weighting 190.0 lb, Patient had the following side effects: dysphagia, hypoaesthesia oral, lip swelling, swollen tongue. During the same period patient was treated with LISINOPRIL AND HYDROCHLOROTHIAZIDE (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ), PROGESTERONE (View Progesterone Review and Progesterone Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ).

7019281-3 | Antinuclear Antibody Positive, Cutaneous Lupus Erythematosus, Epidermal Necrosis, Exfoliative Rash, Histology Abnormal, Pruritus, Red Blood Cell Sedimentation Rate Increased
on Sep 16, 2010 Female patient from UNITED KINGDOM , 85 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?) and was treated with Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: antinuclear antibody positive, cutaneous lupus erythematosus, epidermal necrosis, exfoliative rash, histology abnormal, pruritus, red blood cell sedimentation rate increased. Omeprazole dosage: . During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), BENDROFLUMETHIAZIDE (BENDROFLUMETHIAZIDE) (View Bendroflumethiazide (bendroflumethiazide) Review and Bendroflumethiazide (bendroflumethiazide) Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

7016038-4 | Hypocalcaemia, Tetany
on Sep 09, 2010 Female patient from UNITED KINGDOM , 46 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: hypocalcaemia, tetany. Omeprazole dosage: 20 Mg; Po. During the same period patient was treated with CETOSTEARYL ALCOHOL (CETOSTEARYL ALCOHOL) (View Cetostearyl Alcohol (cetostearyl Alcohol) Review and Cetostearyl Alcohol (cetostearyl Alcohol) Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GLICLAZIDE (GLICLAZIDE) (View Gliclazide (gliclazide) Review and Gliclazide (gliclazide) Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

7015482-9 | Abdominal Pain, Haematemesis, Hepatitis Acute, Liver Function Test Abnormal, Vomiting, Weight Increased
Patient was taking Omeprazole (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), haematemesis, hepatitis acute, liver function test abnormal, vomiting, weight increased on Sep 17, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 28 years of age, weighting 104.7 lb, was diagnosed with abdominal pain upper, vomiting, asthma (What is asthma?), insomnia, stress (What is stress?) and. Omeprazole dosage: . During the same period patient was treated with BUDESONIDE (View Budesonide Review and Budesonide Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ). Patient was hospitalized.

7012984-6 | Femur Fracture
Adverse event was reported on Sep 15, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: 20-40 Mg Daily) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: SWEDEN , 57 years of age, After Omeprazole was administered, patient had the following side effects: femur fracture. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), RISEDRONATE SODIUM (View Risedronate Sodium Review and Risedronate Sodium Label ).

7011867-5 | Alanine Aminotransferase Increased, Jaundice Cholestatic
on Sep 14, 2010 Male patient from UNITED KINGDOM , 60 years of age, weighting 156.5 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, gliosarcoma, constipation (What is constipation?) and was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, jaundice cholestatic. Omeprazole dosage: . During the same period patient was treated with PROCARBAZINE (View Procarbazine Review and Procarbazine Label ), LOMUSTINE (View Lomustine Review and Lomustine Label ), HERBAL REMEDY (View Herbal Remedy Review and Herbal Remedy Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ). Patient was hospitalized.

7011858-4 | Cutaneous Lupus Erythematosus
on Sep 16, 2010 Female patient from GERMANY , 78 years of age, was diagnosed with temporal arteritis and was treated with Omeprazole (View Usage). Patient had the following side effects: cutaneous lupus erythematosus. Omeprazole dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

7011849-3 | Cutaneous Lupus Erythematosus
Patient was taking Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: cutaneous lupus erythematosus on Sep 16, 2010 from GERMANY Additional patient health information: Female patient , 85 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?) and. Omeprazole dosage: . During the same period patient was treated with MELOXICAM (View Meloxicam Review and Meloxicam Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ).

7010430-X | Hypocalcaemia, Tetany
Adverse event was reported on Sep 09, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: ) was diagnosed with gastrooesophageal reflux disease, atrial fibrillation (What is atrial fibrillation?), cardiac failure chronic and. Location: UNITED KINGDOM , 46 years of age, weighting 304.2 lb, Patient experienced the following unwanted or unexpected effects: hypocalcaemia, tetany. During the same period patient was treated with AQUEOUS /00662801/ (View Aqueous /00662801/ Review and Aqueous /00662801/ Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ).

7007921-4 | Blood Pressure Increased, Cerebral Haemorrhage, Intracranial Aneurysm
on Sep 05, 2010 Male patient from UNITED KINGDOM , 69 years of age, was treated with Omeprazole (View Usage). Patient had the following side effects: blood pressure increased, cerebral haemorrhage, intracranial aneurysm. Omeprazole dosage: 20 Mg Milligram(s). During the same period patient was treated with CIPRALEX ACTIVE SUBSTANCES: ESCITALOPRAM (10 Mg Milligram(s) Sep Dosages/interval: 1 In 1 Day) (View Cipralex Active Substances: Escitalopram Review and Cipralex Active Substances: Escitalopram Label ).

7006497-5 | Abdominal Distension, Abdominal Pain Upper, Product Odour Abnormal
on Sep 21, 2010 Female patient from UNITED STATES , 77 years of age, was treated with Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: abdominal distension, abdominal pain upper, product odour abnormal. Omeprazole dosage: Take 1 Capsule Twice Daily.

7006299-X | Cutaneous Lupus Erythematosus
Patient was taking Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: cutaneous lupus erythematosus on Sep 02, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 85 years of age, . Omeprazole dosage: . During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), BENDROFLUMETHIAZIDE (BENDROFLUMETHIAZIDE) (View Bendroflumethiazide (bendroflumethiazide) Review and Bendroflumethiazide (bendroflumethiazide) Label ), ISOSORBIDE MONITRATE (ISOSORBIDE MONONITRATE) (View Isosorbide Monitrate (isosorbide Mononitrate) Review and Isosorbide Monitrate (isosorbide Mononitrate) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ).

7006286-1 | Cutaneous Lupus Erythematosus
Adverse event was reported on Sep 02, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 78 years of age, Patient had the following side effects: cutaneous lupus erythematosus. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ISOSORBIDE MONONITRATE (ISOSORIBDE MONONITRATE) (View Isosorbide Mononitrate (isosoribde Mononitrate) Review and Isosorbide Mononitrate (isosoribde Mononitrate) Label ).

7005225-7 | Product Substitution Issue
on Sep 20, 2010 Male patient from UNITED STATES , 65 years of age, weighting 225.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: product substitution issue. Omeprazole dosage: 20mg 1 Perday.

7005042-8 | Diarrhoea, Electrocardiogram Qt Prolonged, Electrocardiogram St Segment Depression, Hypocalcaemia, Hypokalaemia, Hypomagnesaemia
on Aug 24, 2010 Female patient from NETHERLANDS , 62 years of age, was diagnosed with barrett's oesophagus and was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, electrocardiogram qt prolonged, electrocardiogram st segment depression, hypocalcaemia, hypokalaemia, hypomagnesaemia. Omeprazole dosage: 40 Mg;qd. During the same period patient was treated with RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ). Patient was hospitalized.

7004784-8 | Blood Homocysteine Increased, Vitamin B12 Deficiency
Patient was taking Omeprazole (View Usage). Patient had the following side effects: blood homocysteine increased, vitamin b12 deficiency on Sep 04, 2010 from SPAIN Additional patient health information: Female patient , 78 years of age, was diagnosed with vitamin b12 deficiency and. Omeprazole dosage: . During the same period patient was treated with METFORMIN HCL (2.550 Mg; Qd) (View Metformin Hcl Review and Metformin Hcl Label ).

7003597-0 | Hypocalcaemia, Tetany
Adverse event was reported on Sep 09, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: 20 Mg, Oral) was diagnosed with gastrooesophageal reflux disease and. Location: UNITED KINGDOM , 46 years of age, weighting 304.2 lb, After Omeprazole was administered, patient had the following side effects: hypocalcaemia, tetany. During the same period patient was treated with AQUEOUS CREAM (CETOSTEARYL ALCOHOL) (View Aqueous Cream (cetostearyl Alcohol) Review and Aqueous Cream (cetostearyl Alcohol) Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FUROSEMIDE (FUROSE(NIDE) (View Furosemide (furose(nide) Review and Furosemide (furose(nide) Label ), GLICLAZIDE (GLICLAZIDE) (View Gliclazide (gliclazide) Review and Gliclazide (gliclazide) Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

7003577-5 | Hypomagnesaemia
on Sep 08, 2010 Female patient from UNITED KINGDOM , 38 years of age, weighting 112.4 lb, was diagnosed with dyspepsia and was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: hypomagnesaemia. Omeprazole dosage: 20 Mg, Oral. During the same period patient was treated with LANSOPRAZOLE (30 Mg, Oral) (View Lansoprazole Review and Lansoprazole Label ), CYCLIZINE (CYCLIZINE) (View Cyclizine (cyclizine) Review and Cyclizine (cyclizine) Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ).

7003481-2 | Dilatation Intrahepatic Duct Acquired, Hepatotoxicity, Venoocclusive Liver Disease
on Sep 01, 2010 Female patient from UNITED KINGDOM , 19 years of age, was diagnosed with pain (What is pain?) and was treated with Omeprazole (View Usage). Patient had the following side effects: dilatation intrahepatic duct acquired, hepatotoxicity, venoocclusive liver disease. Omeprazole dosage: . During the same period patient was treated with CICLOSPORIN ACTIVE SUBSTANCES: CICLOSPORIN (View Ciclosporin Active Substances: Ciclosporin Review and Ciclosporin Active Substances: Ciclosporin Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), CASPOFUNGIN ACETATE (70 Mg Milligram(s) Separate Dosages: 1, Intravenous) (View Caspofungin Acetate Review and Caspofungin Acetate Label ), CHLORPHENIRAMINE MALEATE (10 Mg Milligram(s) Separate Dosages: 4, Intravenous) (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), ETOPOPHOS ACTIVE SUBSTANCES: ETOPOSIDE PHOSPHATE (Intravenous) (View Etopophos Active Substances: Etoposide Phosphate Review and Etopophos Active Substances: Etoposide Phosphate Label ), KETALAR (View Ketalar Review and Ketalar Label ), MORPHINE (Intravenous) (View Morphine Review and Morphine Label ), NORETHISTERONE (15 Mg Milligram(s) Separate Dosages: 3) (View Norethisterone Review and Norethisterone Label ).

7002439-7 | Hypocalcaemia, Tetany
Patient was taking Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: hypocalcaemia, tetany on Sep 09, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 46 years of age, weighting 304.2 lb, was diagnosed with gastrooesophageal reflux disease, atrial fibrillation (What is atrial fibrillation?), cardiac failure chronic and. Omeprazole dosage: . During the same period patient was treated with AQUEOUS CREAM (View Aqueous Cream Review and Aqueous Cream Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ).

7002244-1 | Renal Disorder
Adverse event was reported on Sep 17, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: Cap 20 Mg {1 Daily Then 2 Every Other Day 2009) was diagnosed with gastrooesophageal reflux disease and. Location: UNITED STATES , 71 years of age, weighting 152.0 lb, Patient experienced the following unwanted or unexpected effects: renal disorder.

6999427-3 | Asthma, Bronchospasm
on Sep 10, 2010 Female patient from BRAZIL , 80 years of age, weighting 191.8 lb, was diagnosed with gastritis erosive, asthma (What is asthma?), parkinson's disease (What is parkinson's disease?), diabetes mellitus, depression (What is depression?) and was treated with Omeprazole (View Usage). Patient had the following side effects: asthma (What is asthma?), bronchospasm. Omeprazole dosage: . During the same period patient was treated with SERETIDE (View Seretide Review and Seretide Label ), PROLOPA (View Prolopa Review and Prolopa Label ), CIFRAN (View Cifran Review and Cifran Label ), SINGULAIR (View Singulair Review and Singulair Label ), AMARYL (View Amaryl Review and Amaryl Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ). Patient was hospitalized.

6999411-X | Blood Creatine Increased, Renal Failure, Tubulointerstitial Nephritis
on Sep 09, 2010 Female patient from UNITED STATES , 44 years of age, weighting 180.0 lb, was diagnosed with dyspepsia, gastrooesophageal reflux disease, blood cholesterol increased and was treated with Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: blood creatine increased, renal failure, tubulointerstitial nephritis. Omeprazole dosage: . During the same period patient was treated with PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), MAXZIDE (37.5/25mg - 1/2 Tablet) (View Maxzide Review and Maxzide Label ).

6995090-6 | Fall, Femoral Neck Fracture, Hepatic Enzyme Increased, Joint Sprain
Patient was taking Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), femoral neck fracture, hepatic enzyme increased, joint sprain on Aug 31, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 120.0 lb, was diagnosed with gastrooesophageal reflux disease and. Omeprazole dosage: 20 Mg Twice A Day, Oral. During the same period patient was treated with VITAMIN D WITH CALCIUM (View Vitamin D With Calcium Review and Vitamin D With Calcium Label ), MULTIVITAMIN AND MINERAL (View Multivitamin And Mineral Review and Multivitamin And Mineral Label ), TURNS (CALCIUM CARBONATE) (View Turns (calcium Carbonate) Review and Turns (calcium Carbonate) Label ), DARVOCET N (DEXTROPROPOXYPHENE NAPSILATE; PARACETAMOL) (View Darvocet-n (dextropropoxyphene Napsilate; Paracetamol) Review and Darvocet-n (dextropropoxyphene Napsilate; Paracetamol) Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6992299-2 | Hypomagnesaemia
Adverse event was reported on Sep 08, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: ) was diagnosed with dyspepsia and. Location: UNITED KINGDOM , 38 years of age, weighting 112.4 lb, Patient had the following side effects: hypomagnesaemia. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CYCLIZINE (View Cyclizine Review and Cyclizine Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ).

6992283-9 | Gastrooesophageal Reflux Disease, Nausea
on Sep 14, 2010 Female patient from UNITED STATES , 37 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: gastrooesophageal reflux disease, nausea (What is nausea?). Omeprazole dosage: Take 2 Capsules Daily 30 Minutes Before Breakfast.

6992147-0 | Alanine Aminotransferase Increased, Gamma-glutamyltransferase Increased, Renal Failure Acute
on Sep 07, 2010 Female patient from GERMANY , 69 years of age, weighting 158.7 lb, was diagnosed with prophylaxis, thrombocytopenia, hypertension, urinary tract infection (What is urinary tract infection?) and was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, gamma-glutamyltransferase increased, renal failure acute. Omeprazole dosage: . During the same period patient was treated with DECORTIN (View Decortin Review and Decortin Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ). Patient was hospitalized.

6988767-X | Cerebral Haemorrhage
Patient was taking Omeprazole (View Usage). Patient had the following side effects: cerebral haemorrhage on Sep 09, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 69 years of age, . Omeprazole dosage: . During the same period patient was treated with CIPRALEX (View Cipralex Review and Cipralex Label ).

6985130-2 | Burning Mouth Syndrome, Rash
Adverse event was reported on Aug 29, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: ) was diagnosed with gastrooesophageal reflux disease and. Location: UNITED KINGDOM , 52 years of age, After Omeprazole was administered, patient had the following side effects: burning mouth syndrome, rash (What is rash?). During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

6984875-8 | Dysarthria, Facial Paresis, Haemoglobin Decreased, Hemiparesis, Stomatitis
on Aug 27, 2010 Male patient from BELGIUM , 13 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: dysarthria, facial paresis, haemoglobin decreased, hemiparesis, stomatitis. Omeprazole dosage: 20 Mg; Qd. During the same period patient was treated with CYCLOPHOSPHAMIDE (1000 Mg/m**2) (View Cyclophosphamide Review and Cyclophosphamide Label ), BACTRIM (400 Mg;po, Bid) (View Bactrim Review and Bactrim Label ), METHOTREXATE (12 Mg) (View Methotrexate Review and Methotrexate Label ), CYTARABINE (75 Mg/m**2;) (View Cytarabine Review and Cytarabine Label ), THIOGUANINE (View Thioguanine Review and Thioguanine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ASPARAGINASE (View Asparaginase Review and Asparaginase Label ). Patient was hospitalized.

6984780-7 | Flank Pain, Gastrooesophageal Reflux Disease
on Sep 14, 2010 Female patient from UNITED STATES , 78 years of age, was treated with Omeprazole (View Usage). Patient had the following side effects: flank pain, gastrooesophageal reflux disease. Omeprazole dosage: 1 Daily.

6984775-3 | Chest Pain, Dyspepsia, Gastrooesophageal Reflux Disease, Nausea
Patient was taking Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: chest pain (What is chest pain?), dyspepsia, gastrooesophageal reflux disease, nausea (What is nausea?) on Sep 14, 2010 from UNITED STATES Additional patient health information: Female patient , 37 years of age, was diagnosed with gastrooesophageal reflux disease and. Omeprazole dosage: Take 2 Capsules Daily 30 Minutes Before Breakfast.

6984747-9 | Abdominal Pain Upper, Headache, Product Substitution Issue
Adverse event was reported on Sep 14, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: Take 1 Capsule Daily Before A Meal) . Location: UNITED STATES , 78 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, headache (What is headache?), product substitution issue.

6984739-X | Cerebral Haemorrhage
on Sep 06, 2010 Male patient from UNITED KINGDOM , 69 years of age, was treated with Omeprazole (View Usage). Patient had the following side effects: cerebral haemorrhage. Omeprazole dosage: 20 Mg. During the same period patient was treated with CIPRALEX (1/1 Day) (View Cipralex Review and Cipralex Label ).

6983429-7 | Abdominal Pain Upper, Headache, Product Substitution Issue
on Sep 13, 2010 Female patient from UNITED STATES , 78 years of age, was treated with Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: abdominal pain upper, headache (What is headache?), product substitution issue. Omeprazole dosage: Take 1 Capsule Daily Before A Meal.

6982091-7 | Convulsion, Dyspepsia, Hypocalcaemia, Hypokalaemia, Hypomagnesaemia, Hyponatraemia, Lethargy
Patient was taking Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, dyspepsia, hypocalcaemia, hypokalaemia, hypomagnesaemia, hyponatraemia, lethargy on Aug 25, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 38 years of age, was diagnosed with dyspepsia and. Omeprazole dosage: 20 Mg Millgram(s) Sep. Dosages / Interval: 1 In 1 Day Oral. During the same period patient was treated with LANSOPRAZOLE (30 Mg Milligram(s) Oral) (View Lansoprazole Review and Lansoprazole Label ), CYCLIZINE (View Cyclizine Review and Cyclizine Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ).

6980680-7 | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Dilatation Intrahepatic Duct Acquired, Hepatotoxicity, Venoocclusive Liver Disease
Adverse event was reported on Sep 01, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 22 years of age, Patient had the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, dilatation intrahepatic duct acquired, hepatotoxicity, venoocclusive liver disease. During the same period patient was treated with ONDANSETRON (8 Mg, 3 In 1 D) (View Ondansetron Review and Ondansetron Label ).

6980656-X | Burning Mouth Syndrome, Rash
on Aug 27, 2010 Female patient from , 52 years of age, was treated with Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: burning mouth syndrome, rash (What is rash?). Omeprazole dosage: .

6980407-9 | Blood Glucose Increased, Blood Potassium Decreased, Blood Sodium Decreased, Hypomagnesaemia
on Aug 25, 2010 Female patient from UNITED KINGDOM , 38 years of age, was diagnosed with dyspepsia and was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, blood potassium decreased, blood sodium decreased, hypomagnesaemia. Omeprazole dosage: 20 Mg; Po. During the same period patient was treated with LANSOPRAZOLE (30 Mg; Po) (View Lansoprazole Review and Lansoprazole Label ), CYCLIZINE (CYCLIZINE) (View Cyclizine (cyclizine) Review and Cyclizine (cyclizine) Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), MORPHINE (View Morphine Review and Morphine Label ), MORPHINE SULFATE INJ (View Morphine Sulfate Inj Review and Morphine Sulfate Inj Label ), PANCREATIN TRIPLE STRENGTH CAP (View Pancreatin Triple Strength Cap Review and Pancreatin Triple Strength Cap Label ), HYOSCINE HBR HYT (View Hyoscine Hbr Hyt Review and Hyoscine Hbr Hyt Label ).

6979689-9 | Burning Mouth Syndrome, Rash
Patient was taking Omeprazole (View Usage). Patient had the following side effects: burning mouth syndrome, rash (What is rash?) on Sep 02, 2010 from Additional patient health information: Female patient , 52 years of age, was diagnosed with gastrooesophageal reflux disease and. Omeprazole dosage: .